Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
about
Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?Mammographic screening and mammographic patterns.Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model.Number needed to screen: development of a statistic for disease screening.Does mammography save lives?Enthusiasm or uncertainty: small area variations in the use of mammography services in Ontario, CanadaMammography and the politics of randomised controlled trials.Organized breast cancer screening programs in CanadaPredictors of mammography use among Canadian women aged 50-69: findings from the 1996/97 National Population Health SurveyHereditary breast cancer. Risk assessment of patients with a family history of breast cancerEffect of breast self-examination techniques on the risk of death from breast cancerManagement of women at increased risk for breast cancer: preliminary results from a new program.Prostate cancer: 4. Screening.Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.Cancer screening trials: nuts and bolts.Reflections on screening mammography and the early detection of breast cancer: A Countercurrents SeriesImpact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age.Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.Baseline characteristics of participants in the randomized national lung screening trialTwenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.Assessing prevention effectiveness using data to drive program decisions.Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality.Factors determining compliance with screening mammographyPrevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.Simulation Procedure in Periodic Cancer Screening TrialsMLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.Process outcomes from a randomized controlled trial comparing tailored mammography interventions delivered via telephone vs. DVD.Clinical practice. Mammographic screening for breast cancerPoint: Mammography screening-sticking to the scienceGenetic counseling content: How does it impact health behavior?A meta-analysis of mammographic screening with and without clinical breast examination.At what age should screening mammography be recommended for Asian women?Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography.Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancerImproving work-up of the abnormal mammogram through organized assessment: results from the ontario breast screening programConclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS).Detection and description of small breast masses by residents trained using a standardized clinical breast exam curriculumMammography: reviewing the evidence. Epidemiology aspectTamoxifen therapy in breast cancer control worldwide.
P2860
Q24554928-F9D37DBC-F652-44CE-B522-144DD8520B2FQ24803203-87592F35-277D-4E9E-894E-6C67EB7C9AD8Q24813875-B1F00587-9B3E-42E4-B2C5-76BA86C0F12BQ30238956-A622036D-5A3A-4E04-B8AF-7A0B972544E3Q30454244-3024B819-2A06-41E5-8F06-A9FA0D0270C6Q33609558-EB77C941-F6B5-41A2-A601-081B6651C06AQ33704467-46AC36C5-A073-4FBC-B9B1-6F41E381C05DQ33792395-39F45463-3E49-4975-A5FC-908269FCFD8BQ33954255-C28E1598-35BC-4A97-81E7-A36587146A0FQ33955170-12730B0A-BCB2-4502-850C-79D926C47E53Q33964985-A653BCF8-7FB6-404A-B301-56A72988B5A2Q34026143-5577B9CC-8475-4CCA-BCC8-FB7BFDBC0A48Q34026173-CD35A183-2CEF-43E1-9C55-3C9F77B1C116Q34029854-F3F40A6A-F96B-4BD0-AB90-D0B3DABFE650Q34032583-EA082467-4C5B-4427-BB4D-9E55DB969A79Q34073143-7432FEB3-CF3D-4AFC-95A3-56E274AD7867Q34305881-D4327E70-24E6-4268-AE36-CFDA172A5328Q34305889-91CE14BE-4A8E-49C2-BEC5-8C9B596EFF5EQ34343656-6DDD7C44-5B44-47F4-ACB1-AAF4D07414F6Q34366877-85A12C33-055D-48C5-A8FF-C83022F8BC78Q34403715-69785273-AE1D-41A0-B48A-06CBB49F616FQ34453681-151F7D41-7295-47F1-9103-45936F8952D7Q34492408-D20C5933-BB1F-48E9-87B4-E952277A45C0Q34711910-EAF30FC6-ABC6-4062-98BB-CA93E27CEF95Q34712222-8B22A82C-D2AB-4CA3-B0AD-9EF299DFBBB9Q34803780-20ACAAB3-8FA9-4217-91E9-A841195BBAACQ34977102-CB7CCF00-A577-4975-BCF4-3040B7CCAD42Q35106056-F4DDF663-E582-4938-8E2F-6B4D8CCC5BB3Q35113527-580B0C53-771D-485B-A9C3-9959106ADA5AQ35714470-05D45B9F-755C-4BA1-B1EE-D9FC852771AAQ35773039-C32E51D4-F23D-48B3-AB94-290C0166AD24Q35904185-CA390CE4-237E-4E30-B28B-5F55C26D2F51Q35928949-D012FB42-E0B2-4F99-8062-9656116B49C3Q36134512-49418220-535D-430E-8517-54FE9EDB00F5Q36166126-348730CA-6F0D-4EE9-83AD-E9C8DCE1949EQ36278391-623E64BD-D5C9-47BE-A6E6-5B5E45C48BB1Q36460501-31C84294-67FF-42B3-AD7B-005FCC1E6B5AQ36607207-0C358ACB-5492-43BF-A90C-3B5FDD5EE4C1Q36652250-E68C8F1B-B5E3-4F29-B51D-7CE51CADFDD0Q36669816-025A21C9-E110-4C44-8BA1-42C5D692DBCF
P2860
Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@ast
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@en
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@nl
type
label
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@ast
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@en
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@nl
prefLabel
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@ast
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@en
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@nl
P2093
P2860
P1476
Canadian National Breast Scree ...... ong women aged 50 to 59 years.
@en
P2093
P2860
P304
P407
P577
1992-11-01T00:00:00Z